DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Prothena Corporation (NASDAQ: PRTA)

34.04 0.53 (1.58%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PRTA $34.04 1.58%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.22
Previous Close $33.51
Daily Range $33.13 - $34.37
52-Week Range $16.71 - $45.00
Market Cap $1.1B
P/E Ratio -20.69
Dividend (Yield) $0.00 (0.0%)
Volume 244,898
Average Daily Volume 341,600
Current FY EPS -$2.60

Sector

Industry

Prothena Corporation (PRTA) Description

Prothena Corporation plc - Ordinary Shares Website: http://www.prothena.com/

News & Commentary Rss Feed

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and System

Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results

Credit Suisse Analysts Assume Coverage On 10 Biotech Stocks

What's in Store for Prothena (PRTA) this Earnings Season? - Analyst Blog

Prothena (PRTA) Stock Declines Today on Pricing of Secondary Offering

Heavy Early Morning Activity On Prothena (PRTA)

Too Many Secondaries In Biotech - Cramer's Lightning Round (4/6/15)

Can the Uptrend Continue for Prothena (PRTA)? - Tale of the Tape

The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases

This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients

Phase 1 trial results for Prothena Corporation's PRX-002 could indicate that this drug may help treat Parkinson's disease someday.

See More PRTA News...